Healthcare company Abbott Laboratories (ABT.N) has won U.S. antitrust approval for its proposed $25 billion acquisition of medical device maker St. Jude Medical Inc (STJ.N), the U.S. Federal Trade Commission said on...
TA Associates picks up 4% stake in publicly traded Shilpa Medicare
Boston-headquartered private equity fund TA Associates has picked up close to a 4% stake in publicly traded mid-sized pharmaceuticals manufacturer Shilpa MedicareBSE 2.18 %. The fund has invested approximately Rs. 175...
U.S. regulator poised to approve Abbott purchase of St Jude – sources
U.S. antitrust enforcers are poised to approve health care company Abbott Laboratories’ (ABT.N) purchase of medical device maker St. Jude Medical Inc (STJ.N), two sources knowledgeable about the deal said on...
Sun Pharma to acquire oncology product from Novartis for $175 mn
Drug major Sun Pharmaceutical IndustriesBSE 2.31 % today said it will acquire a branded oncology product, Odomzo, from NovartisBSE 1.84 % for an upfront payment of $ 175 million. The agreement has been signed between...
Brazil’s Hypermarcas to sell diaper unit to Ontex, source says
Hypermarcas SA (HYPE3.SA), Brazil’s most diversified pharmaceutical firm, has agreed to sell a diaper business to Belgium’s Ontex Group NV (ONTEX.BR) for about 1 billion reais ($300 million) in cash, a...
Allergan to buy Acelity’s tissue unit LifeCell for $2.9 billion
Drugmaker Allergan Plc said on Tuesday it would buy LifeCell, a regenerative medicine unit owned by privately held Acelity LP Inc, for $2.9 billion in cash, bringing the number of deals it has made this year to an even...
Sanofi’s takeover talks with Actelion progressing: source
Talks between Actelion (ATLN.S) and Sanofi (SASY.PA) are making progress, despite investors’ fears that the Swiss biotech firm’s chief executive and founder might not want to sell, a person with direct...
Sun Pharma completes acquisition of 85% stake in JSC Biosintez
Drug major Sun PharmaceuticalBSE -1.09 % today said it has completed the acquisition of 85.1 per cent stake in Russia-based JSC Biosintez. All necessary formalities for the closure of transaction have been concluded and...
CCI clears Abbott-St Jude deal subject to ‘voluntary remedies’
NEW DELHI: Competition Commission has approved pharma major Abbott Laboratories’ proposed acquisition of heart device maker St Jude Medical Inc, subject to certain “voluntary remedies”. Both the...
Sun Pharma completes acquisition of Ocular Technologies Sarl
Sun Pharma today said it has completed the acquisition of the US-based eye care specialist Ocular Technologies Sarl. “All the necessary formalities for a closure of the said transaction have been concluded and the...
Lonza to buy U.S. drug capsule maker Capsugel from KKR for $5.5 billion
Swiss pharmaceutical supplier Lonza Group AG on Thursday announced a deal to buy Capsugel, a U.S. maker of capsules and other drug delivery systems, from KKR & Co LP for $5.5 billion in cash to broaden its product...
Carlyle set to acquire stake in vaccine maker Bharat Biotech
US-based private equity firm Carlyle Group is set to acquire a minority stake in Hyderabad-based vaccine manufacturer Bharat Biotech International Ltd, according to two people familiar with the development. The...
